Snowball logo
logo
6882

Xiamen Amoytop Biotech Co Ltd

688278 SHG
¥52.05-¥2.46  (4.51%)
Estimate
P/E
19.8
EPS
2.63
Beta
-0.16
Growth
Revenue, YoY
18.48%
Net income, YoY
-9.68%
FCF, YoY
-59.52%
Forecast
P/E (FWD)
15.2
EPS (FWD)
3.42
About the company
Ticker
688278
ISIN
CNE100003RT3
Country
China
Sector (GICS)
Healthcare
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.

Frequently asked questions

What sector does Xiamen Amoytop Biotech Co Ltd (688278) operate in?

Xiamen Amoytop Biotech Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Xiamen Amoytop Biotech Co Ltd (688278) current stock price?

As of the latest data, Xiamen Amoytop Biotech Co Ltd stock price is CN¥52.05, with a previous close of CN¥54.51. Xiamen Amoytop Biotech Co Ltd lost -CN¥2.46 in the last trading session, representing a -4.51% loss.

What is Xiamen Amoytop Biotech Co Ltd (688278) current market capitalization?

Xiamen Amoytop Biotech Co Ltd market cap is approximately 21.25 billion.

What is Xiamen Amoytop Biotech Co Ltd (688278) Earnings Per Share (EPS)?

The trailing EPS is CN¥2.63, and the forward EPS is CN¥3.42.

What is Xiamen Amoytop Biotech Co Ltd (688278) Price-to-Earnings (P/E) ratio?

Xiamen Amoytop Biotech Co Ltd current P/E ratio is 19.79, with a forward P/E of 15.22.

Does Xiamen Amoytop Biotech Co Ltd (688278) pay dividends?

No. Xiamen Amoytop Biotech Co Ltd does not pay a dividend.

What is Xiamen Amoytop Biotech Co Ltd (688278) beta (volatility) score?

Xiamen Amoytop Biotech Co Ltd has a beta of -0.160, indicating lower volatility than the overall market.